dbo:abstract
|
- Alimera Sciences, Inc. is a biopharmaceutical company based in Alpharetta, Georgia that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. The company's main focus is on diseases affecting the back of the eye, or retina. Its main product is Iluvien, a fluocinolone acetonide intravitreal implant. (en)
|
dbo:foundingYear
| |
dbo:industry
| |
dbo:keyPerson
| |
dbo:location
| |
dbo:product
| |
dbo:revenue
| |
dbo:thumbnail
| |
dbo:type
| |
dbo:wikiPageExternalLink
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 8830 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:foundation
| |
dbp:homepage
| |
dbp:imageCaption
|
- Alimera Sciences headquarters in Alpharetta (en)
|
dbp:industry
| |
dbp:keyPeople
| |
dbp:location
| |
dbp:name
|
- Alimera Sciences Inc. (en)
|
dbp:products
| |
dbp:revenue
| |
dbp:tradedAs
|
- Russell Microcap Index component (en)
- NASDAQ:ALIM (en)
|
dbp:type
| |
dbp:wikiPageUsesTemplate
| |
dct:subject
| |
rdf:type
| |
rdfs:comment
|
- Alimera Sciences, Inc. is a biopharmaceutical company based in Alpharetta, Georgia that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. The company's main focus is on diseases affecting the back of the eye, or retina. Its main product is Iluvien, a fluocinolone acetonide intravitreal implant. (en)
|
rdfs:label
| |
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:depiction
| |
foaf:homepage
| |
foaf:isPrimaryTopicOf
| |
foaf:name
|
- Alimera Sciences Inc. (en)
|
is dbo:wikiPageRedirects
of | |
is dbo:wikiPageWikiLink
of | |
is foaf:primaryTopic
of | |